eXoZymes, Inc.
Price Action
Technical Summary
CONSOLIDATINGeXoZymes, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 45), showing significant lag compared to the market leaders. Earnings contraction of 35% provides fundamental context to the price action. Investors should exercise caution due to high volatility (74% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $10.48 | -4.58% | BELOW |
| 50 SMA | $8.96 | +11.62% | ABOVE |
| 100 SMA | $9.91 | +0.87% | ABOVE |
| 150 SMA | $11.31 | -11.59% | BELOW |
| 200 SMA | $11.30 | -11.51% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is EXOZ in an uptrend right now?
EXOZ has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is EXOZ overbought or oversold?
EXOZ's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.
Is EXOZ outperforming the market?
EXOZ has a Relative Strength (RS) Rating of 45 out of 99. EXOZ is currently lagging the broader market.
Where is EXOZ in its 52-week range?
EXOZ is trading at $10.00, which is 54% of its 52-week high ($18.40) and 26% above its 52-week low ($7.08).
How volatile is EXOZ?
EXOZ has a Beta of 1.04 and 52-week volatility of 74%. It's more volatile than the S&P 500 - expect bigger swings.